Papers by Srisakul Chirakarnjanakorn
Journal of the Medical Association of Thailand, Apr 15, 2021
<jats:p>In 2011, the Heart Association of Thailand (HAT) approved the first Thai guideline ... more <jats:p>In 2011, the Heart Association of Thailand (HAT) approved the first Thai guideline for the diagnosis and management of patients with pulmonary hypertension (PH). Since then, significant changes have occurred in the diagnosis and management of patients with PH, such as risk assessment and new strategies for combination therapies based on the 2015 European Society of Cardiology (ESC)/European Respiratory Society (ERS) pulmonary hypertension guidelines. The most recently updated definition of PH was from the Sixth World Symposium on Pulmonary Hypertension in 2018. Hence, HAT has revised the Thai guidelines for the diagnosis and management of patients with PH, which was approved by the Royal College of Physicians of Thailand in 2019. These guidelines are intended for use by 1) general practitioners for preliminary diagnoses and referral to a PH referral center and 2) specialist physicians such as cardiologists and pulmonologists, to collaborate in the caring process and diagnosis and management, including the use of Pulmonary artery hypertension (PAH)-specific drugs. The guidelines were written in Thai language to be easily understood and approved by HAT and the Royal College of Physicians of Thailand in 2019. The current executive summary is aimed to highlight important details of the 2020 Thai Pulmonary Hypertension Guidelines for a broader distribution. This updated version of the executive summary of the guidelines is aimed to achieve three objectives, 1) early diagnosis by using the algorithm, including pathophysiology into one of five PH groups, 2) risk assessment for PAH patients into low, intermediate, or high risk, and 3) sequential combination therapy as indicated by the risk assessment for PAH-specific drugs to maintain PAH patients within the low-risk group as much as possible to improve their long-term survival. Keywords: Guideline, Pulmonary hypertension, Diagnosis, Management</jats:p>
Sixty-one years old man came to our hospital due to progressive dyspnea. The physical examination... more Sixty-one years old man came to our hospital due to progressive dyspnea. The physical examination revealed left parasternal heaving, loud P2, pansystoic murmur grade III/IV at left lower sternal border with increasing intensity during inspiration, compatible with tricuspid regurgitation (TR) with pulmonary hypertension (PHT). Transthoracic echocardiography (TTE) demonstrated dilated right ventricle (RV) and right atrium (RA), severe TR, RV systolic pressure 70 mmHg. No atrial septal defect (ASD) was detected. TTE findings were compatible with volume overload of right heart. However, sensitivities of
Heart & Lung, 2021
BACKGROUND Buddhist walking meditation (BWM) is widely practiced in many countries. However, ther... more BACKGROUND Buddhist walking meditation (BWM) is widely practiced in many countries. However, there is a lack of evidence relating to its effectiveness for patients with heart failure (HF). PURPOSE To determine the effects of a six-week BWM program on exercise capacity, quality of life, and hemodynamic response in patients with chronic HF. METHODS Patients with HF were randomly assigned to a BWM program or an aerobic exercise program. Each group trained at least three times a week during the six-week study period. The outcome measures included exercise capacity (six-minute walk test), disease-specific quality of life (Minnesota Living with Heart Failure Questionnaire), and hemodynamic response (blood pressure and heart rate) immediately after the six weeks of training. RESULTS The study enrolled 48 patients with a mean age of 65 years and a New York Heart Association functional class of II and III. At baseline, there were no significant differences in their clinical and demographic characteristics or the outcome measures. Although six patients withdrew, all participants were included in the intention-to-treat analysis. There was no statistically significant increase in the functional capacity of the BWM group; however, there was a significant improvement for the aerobic group. With both groups, there was no significant improvement in quality of life or most hemodynamic responses. CONCLUSIONS The six-week BWM program did not improve the functional capacity, quality of life, or hemodynamic characteristics of the HF patients, compared with the values of the patients in the aerobic exercise program.
Journal of the American College of Cardiology, 2020
Background: Non-bacterial thrombotic endocarditis (NBTE) is an uncommon entity that should be con... more Background: Non-bacterial thrombotic endocarditis (NBTE) is an uncommon entity that should be considered in patients with thromboembolic events. Once suspected, work-up for hypercoagulable state, autoimmune disorders and malignancy are warranted. Case: A 54-year-old woman presented with an acute ischemic stroke in the left middle cerebral and left posterior cerebral artery territories. Echocardiography revealed preserved LV systolic function, apical dyskinesis with an apical thrombus (Figure 1A) and an RV thrombus. There was a 1.3 cm non-oscillating mass attached to the atrial side of the posterior mitral leaflet (Figure 1B, C) and moderate MR (Figure 1D). Decision-making: She refused to undergo a TEE. She was afebrile, antibiotics were started and blood cultures came back negative. NBTE was suspected and enoxaparin was started with subsequent warfarin. Work-up for hypercoagulable state was negative. One month later, she had acute limb ischemia. Lower extremity CTA demonstrated acute occlusion of the right popliteal artery and left tibioperoneal trunk. Incidentally, ovarian cancer with peritoneal metastasis was found. While on enoxaparin, she developed a DVT and pulmonary embolism (Figure 2). She underwent ovarian surgery and chemotherapy. At 3 months, the echocardiogram findings improved. Conclusion: This case highlights the diagnostic challenges of NBTE. Clinical and echocardiographic features in the context of sterile blood cultures are key diagnostic points.
Japanese Heart Journal, 1975
Korean Journal of Transplantation
Background: Patients with non ST-segment elevation acute coronary syndrome (NSTEACS) present with... more Background: Patients with non ST-segment elevation acute coronary syndrome (NSTEACS) present with diverse clinical, electrocardiographic, cardiac biomarker, echocardiographic and angiographic characteristics. We sought to determine whether there was any difference in the indices of left ventricular systolic and diastolic function among subgroups of patients with NSTEACS. Material and Method: We studied 121 consecutive patients (mean age 68.6 + 11.3 years, 45% male) with NSTEACS who underwent comprehensive echocardiography within 48 hours of admission. Two-dimensional and Doppler echocardiography was performed for the evaluation of left ventricular systolic and diastolic function. Results: Non ST-segment elevation myocardial infarction (NSTEMI) and unstable angina (UA) were reported in 59% and 41% of patients, respectively. Clinical characteristics (such as age, gender, cardiovascular risk factors, prior myocardial infarction and revascularization, medication) were not significantly ...
JAMA, 2021
Importance There is limited evidence on the benefits of sacubitril/valsartan vs broader renin ang... more Importance There is limited evidence on the benefits of sacubitril/valsartan vs broader renin angiotensin system inhibitor background therapy on surrogate outcome markers, 6-minute walk distance, and quality of life in patients with heart failure and mildly reduced or preserved left ventricular ejection fraction (LVEF >40%). Objective To evaluate the effect of sacubitril/valsartan on N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, 6-minute walk distance, and quality of life vs background medication-based individualized comparators in patients with chronic heart failure and LVEF of more than 40%. Design, Setting, and Participants A 24-week, randomized, double-blind, parallel group clinical trial (August 2017-October 2019). Of 4632 patients screened at 396 centers in 32 countries, 2572 patients with heart failure, LVEF of more than 40%, elevated NT-proBNP levels, structural heart disease, and reduced quality of life were enrolled (last follow-up, October 28, 2019). Interventions Patients were randomized 1:1 either to sacubitril/valsartan (n = 1286) or to background medication-based individualized comparator (n = 1286), ie, enalapril, valsartan, or placebo stratified by prior use of a renin angiotensin system inhibitor. Main Outcomes and Measures Primary end points were change from baseline in plasma NT-proBNP level at week 12 and in the 6-minute walk distance at week 24. Secondary end points were change from baseline in quality of life measures and New York Heart Association (NYHA) class at 24 weeks. Results Among 2572 randomized patients (mean age, 72.6 years [SD, 8.5 years]; 1301 women [50.7%]), 2240 (87.1%) completed the trial. At baseline, the median NT-proBNP levels were 786 pg/mL in the sacubitril/valsartan group and 760 pg/mL in the comparator group. After 12 weeks, patients in the sacubitril/valsartan group (adjusted geometric mean ratio to baseline, 0.82 pg/mL) had a significantly greater reduction in NT-proBNP levels than did those in the comparator group (adjusted geometric mean ratio to baseline, 0.98 pg/mL) with an adjusted geometric mean ratio of 0.84 (95% CI, 0.80 to 0.88; P < .001). At week 24, there was no significant between-group difference in median change from baseline in the 6-minute walk distance with an increase of 9.7 m vs 12.2 m (adjusted mean difference, -2.5 m; 95% CI, -8.5 to 3.5; P = .42). There was no significant between-group difference in the mean change in the Kansas City Cardiomyopathy Questionnaire clinical summary score (12.3 vs 11.8; mean difference, 0.52; 95% CI, -0.93 to 1.97) or improvement in NYHA class (23.6% vs 24.0% of patients; adjusted odds ratio, 0.98; 95% CI, 0.81 to 1.18). The most frequent adverse events in the sacubitril/valsartan group vs the comparator group were hypotension (14.1% vs 5.5%), albuminuria (12.3% vs 7.6%), and hyperkalemia (11.6% vs 10.9%). Conclusions and Relevance Among patients with heart failure and left ventricular ejection factor of higher than 40%, sacubitril/valsartan treatment compared with standard renin angiotensin system inhibitor treatment or placebo resulted in a significantly greater decrease in plasma N-terminal pro-brain natriuretic peptide levels at 12 weeks but did not significantly improve 6-minute walk distance at 24 weeks. Further research is warranted to evaluate potential clinical benefits of sacubitril/valsartan in these patients. Trial Registration ClinicalTrials.gov Identifier: NCT03066804.
International Journal of Cardiology, 2017
Patients undergoing maintenance hemodialysis develop both structural and functional cardiovascula... more Patients undergoing maintenance hemodialysis develop both structural and functional cardiovascular abnormalities. Despite improvement of dialysis technology, cardiovascular mortality of this population remains high. The pathophysiological mechanisms of these changes are complex and not well understood. It has been postulated that several non-traditional, uremicrelated risk factors, especially the long-term uremic state, which may affect the cardiovascular system. There are many cardiovascular changes that occur in chronic kidney disease including left ventricular hypertrophy, myocardial fibrosis, microvascular disease, accelerated atherosclerosis and arteriosclerosis. These structural and functional changes in patients receiving chronic dialysis make them more susceptible to myocardial ischemia. Hemodialysis itself may adversely affect the cardiovascular system due to non-physiologic fluid removal, leading to hemodynamic instability and initiation of systemic inflammation. In the past decade there has been growing awareness that pathophysiological mechanisms cause cardiovascular dysfunction in patients on chronic dialysis, and there are now pharmacological and non-pharmacological therapies that may improve the poor quality of life and high mortality rate that these patients experience.
Journal of the American College of Cardiology, 2017
Background: There have been no studies looking at the type of insurance utilized by patients in N... more Background: There have been no studies looking at the type of insurance utilized by patients in Non-ST-segment Elevation Myocardial infarction (NSTEMI). The aim of this study was to look at insurance as an independent risk factor in outcome of NSTEMI patients. Methods: This was a retrospective cohort study using the 2013 National Inpatient Sample. The inclusion criteria were age older than 65 years and ICD-9 CM code for diagnosis of NSTEMI. The primary outcome was in-hospital mortality. The secondary outcomes were total hospital charges, length of hospital stay (LOS), percutaneous coronary intervention (PCI) and early PCI (first 48 hours of admission). Multivariate regression analysis models controlled for: age, race, Charlson Comorbidity Index, rural location and hospital region. Independent risk factor was Medicare/Medicaid (group 1) vs private insurance (group 2). Results: 257,510 patients with primary diagnosis of NSTEMI were included in the study. The mean age was 77.5 years and 46.14% of the patients were female. Patients in group 1 had lower odds of in-hospital mortality but had higher mean total charge to the hospital. The LOS, adjusted odds of receiving PCI and early PCI was the same between the two groups. Conclusions: Patients utilizing Medicare/Medicaid and NSTEMI have lower adjusted odds of mortality compared to patients using private insurance. These patients incurred higher costs to the hospital with approximately similar length of stay and same odds of receiving PCI and early PCI.
Circulation, Nov 26, 2013
Journal of the American College of Cardiology, 2016
Pulmonary arterial hypertension (PAH) features intimal proliferation and smooth muscle hypertroph... more Pulmonary arterial hypertension (PAH) features intimal proliferation and smooth muscle hypertrophy of pulmonary vasculature. Resultant increased afterload leads to right ventricular (RV) failure. The metabolic state of cardiac myocytes is thought to determine how the RV responds to this increased
Circulation, Nov 26, 2013
Background: Mortality remains high following orthotopic heart transplantation (OHT), despite impr... more Background: Mortality remains high following orthotopic heart transplantation (OHT), despite improvement in therapies. Cardiac allograft vasculopathy (CAV) is a cause of death beyond first year after OHT. Dobutamine stress echocardiography (DSE) is performed to evaluate for CAV. We sought to determine predictors of long-term mortality in OHT patients undergoing DSE. Methods: We studied 391 patients (62±11 years, 75% male) with a prior history of OHT (performed between 1984-2011, mean duration 7.2±3.3 years), who underwent DSE between 1998-2012. Patient with submaximal heart rate response & prior revascularization (following OHT) were excluded. Baseline clinical, demographic parameters including all-cause mortality were collected. Conventional echocardiographic & DSE data were recorded. Hard events included death or re-transplantation. Results: Mean left ventricular ejection fraction & end-systolic dimension were 57±6% and 2.8±0.6 cm, respectively. At rest, 3% patients had ≥2+ mitral regurgitation, 29% ≥2+ tricuspid regurgitation & 10% right ventricular dysfunction, with a mean right ventricular systolic pressure of 31±8 mm Hg. On DSE, predicted maximal heart rate was 89±5%, while only 19 patients (5%) were positive for ischemia. Mean glomerular filtration rate was 62±32 mL/min. There were 36% diabetics, 82% hypertensives & 5% dyslipidemics. 23% patients had cytomegalovirus infection, 19% with persistent grade ≥ 2 cellular rejection, 3% with antibody mediated infection & 9% had non-dermatologic cancer during follow-up. During a mean follow-up of 4.7 years (interquartile range 2-8 years), 109 patients (28%) had an event (4 had a re-transplant). Results of Cox survival analysis are shown in Figure 1. Ischemia on DSE did not independently predict events. Conclusions: In OHT patients undergoing follow-up DSE, only GFR & appearance of non-dermatologic cancer predicted long-term events. No DSE parameters independently predicted long-term outcomes.
Thirty-five years old female patient presented with progressive dyspnea with congestive symptom f... more Thirty-five years old female patient presented with progressive dyspnea with congestive symptom for one month. The physical examination found pansystolic murmur grade III/IV at apex radiating to left lower sternal border consistent with mitral regurgitation (MR). Transthoracic echocardiography (TTE) revealed severe MR due to prolapse of posterior mitral leaflet. Although the adequate initial evaluation by TTE, transesophageal echocardiography (TEE) was performed
Journal of the American Society of Echocardiography, 2015
Pericardiectomy is an effective intervention for constrictive pericarditis. Speckle-tracking echo... more Pericardiectomy is an effective intervention for constrictive pericarditis. Speckle-tracking echocardiography can provide quantitative information not only about longitudinal strain (LS) but about longitudinal displacement (LD) and septal-to-lateral rotational displacement (SLRD). The aim of this study was to investigate whether pericardiectomy improves myocardial mechanics using speckle-tracking analysis. Eighty-three patients with constrictive pericarditis who underwent echocardiography were retrospectively assessed (mean age, 58 ± 12 years; 72 men; 50 idiopathic, 20 postoperative, four viral, three radiation, and six others) and compared with 20 healthy volunteers. LD and SLRD were measured from the apical four-chamber view and global LS from three apical views. LD was less in the constrictive pericarditis group compared with control subjects (P &amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt; .001). Only lateral LS was significantly less than that of control subjects (P &amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt; .001), but septal LS was similar (P = .48). In pre- and post-pericardial surgery comparisons (n = 27), values of septal and lateral LD were almost identical (mean, 13.6 ± 4.7 vs 13.3 ± 5.4 mm; P = .70) before pericardiectomy, but septal LD decreased (mean, 9.3 ± 3.5 mm; P &amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt; .001) and lateral LD increased (mean, 16.8 ± 4.7 mm; P = .0106) after the surgery, even though the difference in LS between the septal and lateral walls decreased (from 5.6 ± 5.3% to 2.5 ± 4.2%, P = .008). Systolic whole-heart swinging motion significantly increased to a counterclockwise direction after surgery (mean SLRD, -0.8 ± 3.3° vs 2.1 ± 3.0°; P = .001). Although the change in SLRD after pericardiectomy was not different between patients with decreases and increases in New York Heart Association class, SLRD change was significantly greater in patients who received fewer diuretics after surgery (mean, 4.00 ± 0.91 vs 0.27 ± 1.47; P = .027). After surgical removal of the pericardium, LD of the septal and lateral walls became significantly different, and counterclockwise SLRD increased, reflecting loss of pericardial support.
Clinical journal of the American Society of Nephrology : CJASN, Jan 6, 2015
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2012
Echocardiography is usually performed to quantify the severity of regurgitation. Magnetic resonan... more Echocardiography is usually performed to quantify the severity of regurgitation. Magnetic resonance imaging (MRI) can also quantify mitral regurgitation. This study was performed to determine whether MRI can reliably quantify the severity of mitral regurgitation when compared with echocardiography The authors retrospectively studied patients who underwent cardiac MRI between January 2008 and January 2011. Echocardiography was performed within 3 months of MRI. Mitral regurgitation was quantified by 3 methods of MRI; 1) difference of left ventricular stroke volume and right ventricular stroke volume, 2) difference of left ventricular stroke volume and forward flow volume in ascending aorta and 3) calculation of regurgitation fraction from the ratio of area of regurgitantjet and area of the left atrium. Proximal isovelocity surface area was the echocardiography parameter for mitral regurgitation. Forty-three subjects (24 women and 19 men; 47 to 85 years of age) were enrolled. Mitral re...
Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2011
Standard aortic root dimensional measurement by the two dimensional echocardiography should be ro... more Standard aortic root dimensional measurement by the two dimensional echocardiography should be routinely performed in all patients. There is limited data on the normal reference on Thai population. Aims of this study were (1) to determine the normal reference of aortic root dimension in Thai population and (2) to determine the difference in the aortic root size in patients with hypertension comparing with normal population. We retrospectively reviewed 81 patients who had the transthoracic echocardiographic examinations in our echocardiographic lab and had the aortic root measurement data. The patients with ascending aortic aneurysm, aortic dissection, aortic stenosis and/or regurgitation more than mild in degree, Marfan's syndrome and annuloaortic ectasia were excluded. The echocardiographic data of were collected; the aortic root dimensions at four levels; aortic valve annulus, sinus of Valsava, sinotubular junction and tubular parts. Hypertension was indentified if the patient...
The Journal of Thoracic and Cardiovascular Surgery, 2015
Background: Malignancy-associated thoracic radiation leads to radiationassociated cardiac disease... more Background: Malignancy-associated thoracic radiation leads to radiationassociated cardiac disease (RACD) that often necessitates cardiac surgery. Myocardial dysfunction is common in patients with RACD. We sought to determine the predictive value of global left ventricular ejection fraction and long-axis function left ventricular global longitudinal strain (LV-GLS) in such patients. Methods: We studied 163 patients (age, 63 AE 14 years; 74% women) who had RACD and underwent cardiac surgery (20% had reoperations) between 2000 and 2003. In addition to standard echocardiography, LV-GLS (%) was derived from the average of 18 segments in 3 apical views of the left ventricle, using velocity vector imaging. Standard clinical and demographic parameters were recorded. All-cause mortality was recorded. Results: The mean duration between cardiac surgery and the last chest radiation was 18 AE 12 years. The median European System for Cardiac Operative Risk Evaluation (EuroSCORE) was 8, and 88 patients died over 6.6 AE 4 years. A total of 52% of patients had !IIþ mitral regurgitation; 23% of patients had severe aortic stenosis; and 39% of patients had !IIþ tricuspid regurgitation. The mean left ventricular ejection fraction was 54% AE 13%, and the mean LV-GLS was À12.9% AE 4%. In a Cox proportional survival analysis, lower LV-GLS was predictive of mortality in univariable analysis (hazard ratio, 1.07 (95% confidence interval, 1.01-1.14); P ¼ .006); however, after adjustment for other variables, the association became nonsignificant. In patients with a EuroSCORE <median, abnormal LV-GLS (<À14.5%) was associated with significantly higher mortality (48%), compared with those with normal LV-GLS (32%). Conclusions: In patients who have RACD and undergo cardiac surgery, LV-GLS does not sufficiently discriminate and is not independently predictive of long-term outcomes. However, in patients with a low EuroSCORE, abnormal LV-GLS was associated with higher mortality, compared with those with normal LV-GLS.
Journal of Cardiac Failure, 2014
Uploads
Papers by Srisakul Chirakarnjanakorn